ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$47,282,987
Contributions
72%
Program Services
12%
Investments
9%
Fundraising Events
4%
Other
3%
Government Grants
0%
Membership Dues
0%
Expenses in 2024
$88,250,427
Grants
83%
Salaries & Benefits
10%
Other
4%
Fees to Service Providers
2%
Offices, Occupancy & IT
<1%
Advertising & Promotion
<1%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$24,700,317
$34,198,755
+38%
Government Grants
$0
$0
-
Fundraising Events
$5,895,178
$1,846,403
-69%
Program Services
$4,205,157
$5,841,351
+39%
Membership Dues
$0
$0
-
Investments
$3,119,289
$4,100,926
+31%
Other
-$177,921
$1,295,552
-828%
Total Revenues
$37,742,020
$47,282,987
+25%
Expenses
2023
2024
Change
Grants
$47,673,524
$73,252,232
+54%
Benefits to Members
$0
$0
-
Salaries & Benefits
$8,326,107
$8,861,071
+6%
Fees to Service Providers
$2,327,984
$1,786,022
-23%
Advertising & Promotion
$573,425
$448,188
-22%
Offices, Occupancy & IT
$602,586
$696,883
+16%
Interest
$0
$0
-
Depreciation
$43,675
$41,311
-5%
Other
$2,396,287
$3,164,720
+32%
Total Expenses
$61,943,588
$88,250,427
+42%
Net income
2023
2024
Change
Net income
-$24,201,568
-$40,967,440
-69%
Functional Expenses
Summary
2023
2024
Change
Program
$55,585,427
$81,801,493
+47%
Admin
$2,308,982
$2,626,578
+14%
Fundraising
$4,049,179
$3,822,356
-6%
Total Expenses
$61,943,588
$88,250,427
+42%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)